Asia Business News | Sunday, July 06, 2008
RSS 2.0  
The company is a specialist pharmaceutical company committed to the research, development and commercialisation of human therapeutic products for chronic respiratory and autoimmune diseases and the development of an improved lung function test.
Company Fax (02) 9451 3622 
Company Principal Sector Health & Pharm 
Company Principal Industry Biotechnology 
Company Listed 2003/11/10 
Company Homepage www.pharmaxis.com.au/
 
Stock Exchange Stock Code
  ASX:PXSPXS
NASDAQPXSL
News Reader RSS   PHARMAXIS LTD
 Aust Market Wrap, (ASX: ORG), (ASX: MCC), (ASX: BPT), (ASX: PXS), (ASX: CAZ), (ASX: MBL) (AUG 29, 2007)
 Pharmaxis confirms ADR position and deposits with the Bank Of New York (NOV 10, 2005)
 Pharmaxis Ltd Announces Pricing of Global Capital Raising (NOV 8, 2005)